Park, H. J., Bae, J. S., Kim, K. M., Moon, Y. J., Park, S., Ha, S. H., . . . Jang, K. Y. (2018). The PARP inhibitor olaparib potentiates the effect of the DNA damaging agent doxorubicin in osteosarcoma. J Exp Clin Cancer Res.
Style de citation ChicagoPark, Hye Jeong, et al. "The PARP Inhibitor Olaparib Potentiates the Effect of the DNA Damaging Agent Doxorubicin in Osteosarcoma." J Exp Clin Cancer Res 2018.
Style de citation MLAPark, Hye Jeong, et al. "The PARP Inhibitor Olaparib Potentiates the Effect of the DNA Damaging Agent Doxorubicin in Osteosarcoma." J Exp Clin Cancer Res 2018.
Attention : ces citations peuvent ne pas être correctes à 100%.